United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

22 Sep 2017
Change (% chg)

$0.01 (+0.75%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Jamieson, Brian 

Mr. Brian Jamieson, FCA, is an Independent Non-Executive Chairman of the Board of Mesoblast Ltd., since November 22, 2007. He was Chief Executive of Minter Ellison Melbourne and a partner of the Minter Ellison Revenue Group from 2002 to 2005. Mr. Jamieson retired as Chief Executive of Minter Ellison Melbourne on December 31, 2005. Prior to joining Minter Ellison, he was Chief Executive Officer at KPMG Australia from 1998 to 2000, Managing Partner of KPMG Melbourne and Southern Regions from 1993 to 1998 and Chairman of KPMG Melbourne from 2001 to 2002. Mr. Jamieson was also a KPMG Board Member in Australia, and a member of the USA Management Committee. He is Chairman of Sigma Pharmaceuticals Limited and a Non-Executive Director of the Tatts Group Limited. Mr Jamieson is also a Director and Treasurer of the Bionic Ear Institute. He is a fellow of the Institute of Chartered Accountants in Australia and a Member of the Institute of Company Directors.

Basic Compensation

Total Annual Compensation, AUD 328,320
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 19,308
Fiscal Year Total, AUD 347,628

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --